Evaluation and Management of Elevated Blood Pressure in Children and Adolescents with Attention Deficit Hyperactivity Disorder

被引：3
|
作者：
Yamaguchi, Ikuyo [1 ,2 ]
Hanevold, Coral [1 ,2 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, Div Nephrol, Dept Pediat, 7703 Floyd Curl Dr,Mail Code 7813, San Antonio, TX 78229 USA
[2] Univ Washington, Seattle Childrens Hosp, Div Nephrol, Dept Pediat,Sch Med, 4800 Sand Point Way NE, Seattle, WA 98105 USA
来源：
CURRENT HYPERTENSION REPORTS | 2019年 / 21卷 / 08期
关键词：
ADHD; Pediatric hypertension; Elevated blood pressure; Stimulants; Cardiovascular disease; SERIOUS CARDIOVASCULAR EVENTS; CONGENITAL HEART-DISEASE; DEFICIT/HYPERACTIVITY DISORDER; ADHD MEDICATIONS; CARDIAC SAFETY; UNITED-STATES; HYPERTENSION; POPULATION; STIMULANTS; PREVALENCE;
D O I：
10.1007/s11906-019-0968-1
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
Purpose of ReviewTo understand the impact of attention deficit hyperactivity disorder (ADHD) and its medications on blood pressure (BP) in children and adolescents and provide recommendations for management of elevated BP in children and adolescents with ADHD.Recent FindingsADHD medications have cardiovascular effects including elevated BP. However, the bulk of the evidence indicates that stimulants and other ADHD medications are safe and do not cause severe cardiovascular diseases. BP should be assessed carefully at the time of ADHD diagnosis, because some behavioral changes similar to ADHD may be associated with hypertension.SummaryADHD medications appear to be safe. However, their long-term impact on the cardiovascular system is not clearly understood and needs further investigation. BP should be monitored regularly during ADHD pharmacotherapy in order to optimize the management of both conditions.
引用
收藏
页数：6
相关论文
共 50 条
12345